Bethesda III and IV Thyroid Nodules Managed Nonoperatively after Molecular Testing with Afirma GSC or Thyroseq v3

By sjmartinez • March 31, 2023

Kim NE, Raghunathan RS, Hughes EG, Longstaff XR, Tseng CH, Li S, Cheung DS, Gofnung YA, Famini P, Wu JX, Yeh MW, Livhits MJ. Bethesda III and IV Thyroid Nodules Managed Nonoperatively after Molecular Testing with Afirma GSC or Thyroseq v3. J Clin Endocrinol Metab. 2023 Mar 30:dgad181. doi: 10.1210/clinem/dgad181. Epub ahead of print. PMID: 36995878.

Tags: Endocrinology, General Internal Medicine, indeterminate nodules, molecular testing, nonoperative, Publications, surveillance, thyroid, thyroid cancer

Hyperaldosteronism Remission after Extended Aldosterone Synthase Inhibition

Brown MJ, Turcu AF, Sam R, Kirschner LS, Hamidi O, Eren A, Ben-Shlomo A, Huang W, Bancos I, Hamrahian AH, Freeman MW. Hyperaldosteronism Remission after[...]

Single-cell profiling reveals monocyte mitochondrial dysfunction in patients with cirrhosis progressing to acute-on-chronic liver failure

Wirtz TH, Palomino-Echeverria S, Pollmanns MR, Huergo E, Schreibing F, Reißing J, Sánchez-Garrido C, López-Vicario C, Aransay AM, Baldassare M, Zaccherini G, Pompili E, McCoy[...]

Genetic Correlates of Malignant Behavior in Aggressive Pituitary Tumors

Theodorou A, Benhamida J, Alano T, Armstrong D, Drodge S, Bellantoni M, Braun K, Chen J, Chow F, Drincic A, Goichot B, Heaney AP, Magge[...]